Clinical Trial Update: A Pharmacokinetic Study to Compare the Dosing of Valproic Acid in Subjects With Different Body Weights [Phase 4]

View source ↗

Summary

A Phase 4 pharmacokinetic study evaluated dosing of valproic acid in subjects with different body weights. The study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• VALPROIC ACID (Valproic acid)

Snippet

Sponsor: Northwell Health | Conditions: Healthy, Obesity | Phase 4 | Status: TERMINATED